News

Materials innovation company, Xampla, announces a major commercial advance as Bunzl UK & Ireland add Huhtamaki’s ‘Taste’ hot ...
The progression to a Phase IIb clinical study follows encouraging results from Exonate’s Phase Ib/IIa study in March 2024 1.
Centauri Therapeutics receives an additional $5.1M from CARB-X to progress ABX-01 lead compound to first in human clinical trials CARB-X provides an additional $5.1M to complete the non-clinical ...
Nurturing leads and customers isn’t just about courtesy- it’s a powerful way to boost engagement, conversions, and long-term ...
Our public safety connectivity solutions support the frequency bands most commonly used by public safety, emergency services ...
The Cambridge Index fell 510.5 points or 2.0% to close at 25,435.5, as seven out of the top ten index heavyweights posted ...
The UK life sciences sector remains a cornerstone of the national economy, employing around 300,000 people and contributing ...
PhoreMost Ltd., a next-generation targeted protein degradation (TPD) company progressing a pipeline of degrader therapeutics ...
Surgeons from the robotic surgery team at Addenbrooke’s Hospital in Cambridge have said they don’t believe fully autonomous ...
The anniversary event, held in the magnificent setting of St John’s College brought together PEM’s clients, friends of the ...
Mind Values Leadership (MVL), a specialist provider of coaching, leadership development and organisational consultancy, has ...
Sepura partners with local charity and social enterprise The Phoenix Trust to transform a quiet courtyard at its Cambridge ...